Brepocitinib
Material Identity Review Required
The supplied catalog name and CAS correspondence requires manufacturer confirmation. Confirm the complete material identity before technical qualification.
Identification & Structure
CN1C=NC2=C1C(=O)N(C=N2)CC3=NC(=NO3)CCC4=CC=C(C=C4)Cl
| Product Code | E-14 |
| Product Type | API |
| CAS Number | 1883711-97-4 |
| Molecular Formula | C17H15ClN6O2 |
| Molecular Weight | 370.8 |
| IUPAC Name | 1-[[3-[2-(4-chlorophenyl)ethyl]-1,2,4-oxadiazol-5-yl]methyl]-7-methylpurin-6-one |
| SMILES | CN1C=NC2=C1C(=O)N(C=N2)CC3=NC(=NO3)CCC4=CC=C(C=C4)Cl |
| InChIKey | AWJBWNUUODWOKQ-UHFFFAOYSA-N |
| PubChem CID | 73297271 |
| Quality Parameters | Request current specification and available batch documentation |
Related API
This catalog entry is the API Brepocitinib itself. Review its intended use and the applicable destination-market requirements.
Specifications and available documentation are reviewed against your project requirements. Availability and lead time are confirmed for each enquiry, taking current stock and production schedules into account.
Request a Quote & Documents
Tell us the quantity, specification and destination. We will reply by email with pricing, lead time and the documents available.
Documents on Request
Request current specification and available batch documentation. We will confirm which TDS, SDS, CoA and analytical materials can be shared for this product.
Patent Notice
Supply is reviewed against the destination, patent status and intended use. Products are not offered where the transaction would infringe valid patents or supplementary protection certificates. Where applicable, regulatory-development activities may fall within the Bolar exemption under Article 10(6) of EU Directive 2001/83/EC, as amended by Directive 2004/27/EC, or 35 U.S.C. § 271(e)(1). These provisions have specific conditions; research use alone does not establish an exemption. Buyers must confirm applicable requirements for their jurisdiction and project before ordering. Commercial supply in protected territories requires an applicable legal basis.